Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Bioorg Med Chem Lett. 2010 Jan 11;20(5):1783–1786. doi: 10.1016/j.bmcl.2010.01.010

Table 1.

Anti-HBV activity of the prodrug 3 against wild-type and drug-resistant HBV mutants.

Virus Strain EC50 of 3
(μM)
EC90 of 3
(μM)
Control: 3TC (μM) Control: ADV (μM)
EC50 EC90 EC50 EC90
HBV WT 2.5 8.5 0.2 0.7 1.5 7
HBV-3TC-R1 L180M 2.1 8.6 5.3 20 2.1 8.2
HBV-3TC-R2 M204V 2.4 8.3 >100 >100 1.8 7.2
HBV-3TC-R3 M204I 3 9.2 >100 >100 2 8
HBV-3TC-R4 LMMV 3.1 9.3 >100 >100 2.2 8.3
HBV-ADV-R1 N236T 2.8 8.7 0.2 0.8 7.5 29